Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome
Rett syndrome (RTT) is a neurodevelopmental disease in children that is mainly caused by mutations in the MeCP2 gene, which codes for a transcriptional regulator. The expression of insulin-like growth factor-1 (IGF-1) is reduced in RTT patients and animal models, and IGF-1 treatment is a promising t...
Main Authors: | Zhe-Feng Yuan, Shan-Shan Mao, Jue Shen, Li-Hua Jiang, Lu Xu, Jia-Lu Xu, Feng Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2020.00020/full |
Similar Items
-
Pharmacological Rescue of Nonsense Mutations in Rett Syndrome
by: Popescu, Andreea
Published: (2009) -
Pharmacological Rescue of Nonsense Mutations in Rett Syndrome
by: Popescu, Andreea
Published: (2009) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
by: Ryo Takeguchi, et al.
Published: (2020-02-01) -
The MeCP2E1/E2-BDNF-miR132 Homeostasis Regulatory Network Is Region-Dependent in the Human Brain and Is Impaired in Rett Syndrome Patients
by: Shervin Pejhan, et al.
Published: (2020-08-01) -
Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes
by: Qiping Dong, et al.
Published: (2018-03-01)